Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Paul

Showing results (691-700 of 763) with videos related to

Pageof 77
Sort By:
Medrxiv : the Preprint Server for Health Sciences|July 9, 2024
Targeting myeloperoxidase to reduce neuroinflammation in X-linked dystonia parkinsonismTiziana Petrozziello, Negin J Motlagh, Ranee Z B Monsanto, et al.
Anaesthesia|September 11, 2014
The 5th National Audit Project (NAP5) on accidental awareness during general anaesthesia: protocol, methods and analysis of dataJ J Pandit, J Andrade, D G Bogod, et al.
Early Intervention in Psychiatry|June 30, 2021
Cannabidiol for at risk for psychosis youth: A randomized controlled trialG Paul Amminger, Ashleigh Lin, Melissa Kerr, et al.
British Journal of Anaesthesia|September 11, 2014
5th National Audit Project (NAP5) on accidental awareness during general anaesthesia: protocol, methods, and analysis of dataJ J Pandit, J Andrade, D G Bogod, et al.
Joint Commission Journal on Quality and Patient Safety|August 21, 2015
Clinical Communities at Johns Hopkins Medicine: An Emerging Approach to Quality ImprovementLois J Gould, Patricia A Wachter, Hanan Aboumatar, et al.
Nature Communications|May 25, 2021
Ecology and molecular targets of hypermutation in the global microbiomeSimon Roux, Blair G Paul, Sarah C Bagby, et al.
CNS Neuroscience & Therapeutics|November 5, 2024
Targeting Myeloperoxidase to Reduce Neuroinflammation in X-Linked Dystonia ParkinsonismTiziana Petrozziello, Negin Jalali Motlagh, Ranee Zara B Monsanto, et al.
The New England Journal of Medicine|September 7, 2022
Open-Source Automated Insulin Delivery in Type 1 DiabetesMercedes J Burnside, Dana M Lewis, Hamish R Crocket, et al.
Biological Psychiatry|November 7, 2019
The NEURAPRO Biomarker Analysis: Long-Chain Omega-3 Fatty Acids Improve 6-Month and 12-Month Outcomes in Youths at Ultra-High Risk for PsychosisG Paul Amminger, Barnaby Nelson, Connie Markulev, et al.
Early Intervention in Psychiatry|November 30, 2018
Can antipsychotic dose reduction lead to better functional recovery in first-episode psychosis? A randomized controlled-trial of antipsychotic dose reduction. The reduce trial: Study protocolAmber Weller, John Gleeson, Mario Alvarez-Jimenez, et al.
Pageof 77

Showing results (691-700 of 763) with videos related to

Sort By:
Pageof 77
Medrxiv : the Preprint Server for Health Sciences|July 9, 2024
Targeting myeloperoxidase to reduce neuroinflammation in X-linked dystonia parkinsonismTiziana Petrozziello, Negin J Motlagh, Ranee Z B Monsanto, et al.
Anaesthesia|September 11, 2014
The 5th National Audit Project (NAP5) on accidental awareness during general anaesthesia: protocol, methods and analysis of dataJ J Pandit, J Andrade, D G Bogod, et al.
Early Intervention in Psychiatry|June 30, 2021
Cannabidiol for at risk for psychosis youth: A randomized controlled trialG Paul Amminger, Ashleigh Lin, Melissa Kerr, et al.
British Journal of Anaesthesia|September 11, 2014
5th National Audit Project (NAP5) on accidental awareness during general anaesthesia: protocol, methods, and analysis of dataJ J Pandit, J Andrade, D G Bogod, et al.
Joint Commission Journal on Quality and Patient Safety|August 21, 2015
Clinical Communities at Johns Hopkins Medicine: An Emerging Approach to Quality ImprovementLois J Gould, Patricia A Wachter, Hanan Aboumatar, et al.
Nature Communications|May 25, 2021
Ecology and molecular targets of hypermutation in the global microbiomeSimon Roux, Blair G Paul, Sarah C Bagby, et al.
CNS Neuroscience & Therapeutics|November 5, 2024
Targeting Myeloperoxidase to Reduce Neuroinflammation in X-Linked Dystonia ParkinsonismTiziana Petrozziello, Negin Jalali Motlagh, Ranee Zara B Monsanto, et al.
The New England Journal of Medicine|September 7, 2022
Open-Source Automated Insulin Delivery in Type 1 DiabetesMercedes J Burnside, Dana M Lewis, Hamish R Crocket, et al.
Biological Psychiatry|November 7, 2019
The NEURAPRO Biomarker Analysis: Long-Chain Omega-3 Fatty Acids Improve 6-Month and 12-Month Outcomes in Youths at Ultra-High Risk for PsychosisG Paul Amminger, Barnaby Nelson, Connie Markulev, et al.
Early Intervention in Psychiatry|November 30, 2018
Can antipsychotic dose reduction lead to better functional recovery in first-episode psychosis? A randomized controlled-trial of antipsychotic dose reduction. The reduce trial: Study protocolAmber Weller, John Gleeson, Mario Alvarez-Jimenez, et al.
Pageof 77